Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival

Clinical Immunology

Volumn 142, Issue 3, 2012, Pages 343-350

  Sairafi, Darius ^a   Mattsson, Jonas ^a   Uhlin, Michael ^a   Uzunel, Mehmet ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Graft source; Immune reconstitution; Stem cell transplantation; Thymic function; TREC

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; MELPHALAN; METHOTREXATE; RAPAMYCIN; T CELL RECEPTOR EXCISION CIRCLE; T LYMPHOCYTE RECEPTOR; TACROLIMUS; THYMOCYTE ANTIBODY; TREOSULFAN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; THYMUS FUNCTION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; STEM CELL TRANSPLANTATION; SURVIVAL RATE; THYMUS GLAND; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857357487     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.12.001     Document Type: Article

References (46)

1. Zakrzewski J.L., Goldberg G.L., Smith O.M., van den Brink M.R. Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends. Blood Cells Mol. Dis. 2008, 40:44-47.
2. Small T.N., Papadopoulos E.B., Boulad F., Black P., Castro-Malaspina H., Childs B.H., Collins N., Gillio A., George D., Jakubowski A., Heller G., Fazzari M., Kernan N., MacKinnon S., Szabolcs P., Young J.W., O'Reilly R.J. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999, 93:467-480.
3. Mackall C.L., Punt J.A., Morgan P., Farr A.G., Gress R.E. Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur. J. Immunol. 1998, 28:1886-1893.
4. Douek D.C., Vescio R.A., Betts M.R., Brenchley J.M., Hill B.J., Zhang L., Berenson J.R., Collins R.H., Koup R.A. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000, 355:1875-1881.
5. Mackall C.L., Fleisher T.A., Brown M.R., Andrich M.P., Chen C.C., Feuerstein I.M., Horowitz M.E., Magrath I.T., Shad A.T., Steinberg S.M., et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 1995, 332:143-149.
6. Salaun J., Corbel C., Le-Douarin N.M. Regulatory T cells in the establishment and maintenance of self-tolerance: role of the thymic epithelium. Int. J. Dev. Biol. 2005, 49:137-142.
7. Miura Y., Thoburn C.J., Bright E.C., Phelps M.L., Shin T., Matsui E.C., Matsui W.H., Arai S., Fuchs E.J., Vogelsang G.B., Jones R.J., Hess A.D. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 2004, 104:2187-2193.
8. Storek J., Dawson M.A., Maloney D.G. Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation. Biol. Blood Marrow Transplant. 2003, 9:781-784.
9. Mackall C.L., Bare C.V., Granger L.A., Sharrow S.O., Titus J.A., Gress R.E. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 1996, 156:4609-4616.
10. Bomberger C., Singh-Jairam M., Rodey G., Guerriero A., Yeager A.M., Fleming W.H., Holland H.K., Waller E.K. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood 1998, 91:2588-2600.
11. de Gast G.C., Verdonck L.F., Middeldorp J.M., The T.H., Hekker A., vd Linden J.A., Kreeft H.A., Bast B.J. Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft. Blood 1985, 66:428-431.
12. Arstila T.P., Casrouge A., Baron V., Even J., Kanellopoulos J., Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science 1999, 286:958-961.
13. Weinberg K., Blazar B.R., Wagner J.E., Agura E., Hill B.J., Smogorzewska M., Koup R.A., Betts M.R., Collins R.H., Douek D.C. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 2001, 97:1458-1466.
14. Przybylski G.K., Kreuzer K.A., Siegert W., Schmidt C.A. No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GvHD. J. Appl. Genet. 2007, 48:397-404.
15. Clave E., Busson M., Douay C., Peffault de Latour R., Berrou J., Rabian C., Carmagnat M., Rocha V., Charron D., Socie G., Toubert A. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 2009, 113:6477-6484.
16. Castermans E., Hannon M., Dutrieux J., Humblet-Baron S., Seidel L., Cheynier R., Willems E., Gothot A., Vanbellinghen J.F., Geenen V., Sandmaier B.M., Storb R., Beguin Y., Baron F. Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60years of age. Haematologica 2011, 96:298-306.
17. Jimenez M., Martinez C., Ercilla G., Carreras E., Urbano-Ispizua A., Aymerich M., Villamor N., Amezaga N., Rovira M., Fernandez-Aviles F., Montserrat E. Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults. Transpl. Immunol. 2006, 16:52-59.
18. Clave E., Rocha V., Talvensaari K., Busson M., Douay C., Appert M.L., Rabian C., Carmagnat M., Garnier F., Filion A., Socie G., Gluckman E., Charron D., Toubert A. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 2005, 105:2608-2613.
19. Brown J.A., Stevenson K., Kim H.T., Cutler C., Ballen K., McDonough S., Reynolds C., Herrera M., Liney D., Ho V., Kao G., Armand P., Koreth J., Alyea E., McAfee S., Attar E., Dey B., Spitzer T., Soiffer R., Ritz J., Antin J.H., Boussiotis V.A. Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis. Blood 2010, 115:4111-4119.
20. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-235.
21. Ringden O., Ruutu T., Remberger M., Nikoskelainen J., Volin L., Vindelov L., Parkkali T., Lenhoff S., Sallerfors B., Ljungman P., et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994, 83:2723-2730.
22. Uzunel M., Remberger M., Sairafi D., Hassan Z., Mattsson J., Omazic B., Barkholt L., Ringden O. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning. Transplantation 2006, 82:913-919.
23. Ringden O., Remberger M., Carlens S., Hagglund H., Mattsson J., Aschan J., Lonnqvist B., Klaesson S., Winiarski J., Dalianis T., Olerup O., Sparrelid E., Elmhorn-Rosenborg A., Svahn B.M., Ljungman P. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. Transplantation 1998, 66:620-625.
24. Storb R., Deeg H.J., Whitehead J., Appelbaum F., Beatty P., Bensinger W., Buckner C.D., Clift R., Doney K., Farewell V., et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N. Engl. J. Med. 1986, 314:729-735.
25. Hazenberg M.D., Verschuren M.C., Hamann D., Miedema F., van Dongen J.J. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J. Mol. Med. 2001, 79:631-640.
26. Chung B., Barbara-Burnham L., Barsky L., Weinberg K. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 2001, 98:1601-1606.
27. Jamieson B.D., Douek D.C., Killian S., Hultin L.E., Scripture-Adams D.D., Giorgi J.V., Marelli D., Koup R.A., Zack J.A. Generation of functional thymocytes in the human adult. Immunity 1999, 10:569-575.
28. Picker L.J., Treer J.R., Ferguson-Darnell B., Collins P.A., Buck D., Terstappen L.W. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J. Immunol. 1993, 150:1105-1121.
29. Zlotoff D.A., Sambandam A., Logan T.D., Bell J.J., Schwarz B.A., Bhandoola A. CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus. Blood 2010, 115:1897-1905.
30. Tough D.F., Sprent J. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 1994, 179:1127-1135.
31. Young J.L., Ramage J.M., Gaston J.S., Beverley P.C. In vitro responses of human CD45R0brightRA- and CD45R0-RAbright T cell subsets and their relationship to memory and naive T cells. Eur. J. Immunol. 1997, 27:2383-2390.
32. Heitger A., Neu N., Kern H., Panzer-Grumayer E.R., Greinix H., Nachbaur D., Niederwieser D., Fink F.M. Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood 1997, 90:850-857.
33. Fallen P.R., McGreavey L., Madrigal J.A., Potter M., Ethell M., Prentice H.G., Guimaraes A., Travers P.J. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant. 2003, 32:1001-1014.
34. Remberger M., Sundberg B. Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation. Haematologica 2005, 90:931-938.
35. Hauri-Hohl M.M., Keller M.P., Gill J., Hafen K., Pachlatko E., Boulay T., Peter A., Hollander G.A., Krenger W. Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation. Blood 2007, 109:4080-4088.
36. Villaron E.M., Almeida J., Lopez-Holgado N., Alcoceba M., Sanchez-Abarca L.I., Sanchez-Guijo F.M., Alberca M., Perez-Simon J.A., San Miguel J.F., Del Canizo M.C. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 2004, 89:1421-1427.
37. Lafontaine M., Landry D., Montplaisir S. Human thymic dendritic cells. Microsc. Res. Tech. 1997, 38:267-275.
38. Itoi M., Tsukamoto N., Yoshida H., Amagai T. Mesenchymal cells are required for functional development of thymic epithelial cells. Int. Immunol. 2007, 19:953-964.
39. Champlin R.E., Schmitz N., Horowitz M.M., Chapuis B., Chopra R., Cornelissen J.J., Gale R.P., Goldman J.M., Loberiza F.R., Hertenstein B., Klein J.P., Montserrat E., Zhang M.J., Ringden O., Tomany S.C., Rowlings P.A., Van Hoef M.E., Gratwohl A. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000, 95:3702-3709.
40. Schmitz N., Beksac M., Hasenclever D., Bacigalupo A., Ruutu T., Nagler A., Gluckman E., Russell N., Apperley J.F., Gorin N.C., Szer J., Bradstock K., Buzyn A., Clark P., Borkett K., Gratwohl A. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002, 100:761-767.
41. Ottinger H.D., Beelen D.W., Scheulen B., Schaefer U.W., Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996, 88:2775-2779.
42. Anderson D., DeFor T., Burns L., McGlave P., Miller J., Wagner J., Weisdorf D. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Biol. Blood Marrow Transplant. 2003, 9:52-59.
43. Miller J.S., Prosper F., McCullar V. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997, 90:3098-3105.
44. Sutherland J.S., Spyroglou L., Muirhead J.L., Heng T.S., Prieto-Hinojosa A., Prince H.M., Chidgey A.P., Schwarer A.P., Boyd R.L. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin. Cancer Res. 2008, 14:1138-1149.
45. Min D., Taylor P.A., Panoskaltsis-Mortari A., Chung B., Danilenko D.M., Farrell C., Lacey D.L., Blazar B.R., Weinberg K.I. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002, 99:4592-4600.
46. Fry T.J., Sinha M., Milliron M., Chu Y.W., Kapoor V., Gress R.E., Thomas E., Mackall C.L. Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution. Blood 2004, 104:2794-2800.